Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Sarcopenia Is A Predictor Of Outcomes After Lobectomy.

J. A. Miller, K. Harris, Charles L Roche, S. Dhillon, Athar Battoo, T. Demmy, C. Nwogu, E. Dexter, Mark W. Hennon, A. Picone, K. Attwood, S. Yendamuri
Published 2018 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Background As screening for lung cancer rises, an increase in the diagnosis of early stage lung cancers is expected. Lobectomy remains the standard treatment, but there are alternatives, consideration of which requires an estimation of the risk of surgery. Sarcopenia, irrespective of body mass index, confers a worse prognosis in many groups of patients including those undergoing surgery. Here we examine the association of muscle mass with outcomes for patients undergoing lobectomy. Methods Consecutive patients undergoing lobectomy were retrospectively reviewed. Preoperative computed tomography scans were reviewed, and cross-sectional area of the erector spinae muscles and pectoralis muscles was determined and normalized for height. Univariate and multivariate analyses were then done to examine for an association of muscle mass with morbidity and short- and long-term mortality. Results During the study period, there were 299 lobectomies, 278 of which were done by video assisted thoracoscopic surgery. The average age of the patients was 67.5±10.6 years. Overall complication rate was 52.2%, pneumonia rate was 8.7%, and the 30-day mortality rate was 1.3%. Mean height adjusted-erector spinae muscle cross-sectional area was 10.6±2.6 cm2/m2, and mean height adjusted-pectoralis muscle cross sectional area was 13.3±3.8 cm2/m2. The height adjusted cross sectional areas of the erector spinae and pectoralis muscles were not associated with overall complication rate, rate of pneumonia, readmission, or intensive care unit length of stay. The height adjusted-erector spinae muscle cross sectional area was inversely correlated with 30-day mortality risk, odds ratio 0.77 (95% CI, 0.60-0.98, P=0.036). Mean length of stay was 7.0 days (95% CI, 5.5-8.4 days). Multivariate analysis demonstrated a significant inverse association of the height adjusted-erector spinae muscle cross sectional area with length of stay (P=0.019). Conclusions The height adjusted-erector spinae muscle cross sectional area was significantly associated with 30-day mortality and length of stay in the hospital. Measurement of muscle mass on preoperative computed tomography imaging may have a role to help predict risk of morbidity and mortality prior to lobectomy.
This paper references
10.1378/chest.12-0790
American College of Chest Physicians and Society of Thoracic Surgeons consensus statement for evaluation and management for high-risk patients with stage I non-small cell lung cancer.
J. Donington (2012)
10.1093/GERONA/56.3.M146
Frailty in older adults: evidence for a phenotype.
L. Fried (2001)
10.1016/j.acra.2017.02.008
Diagnosing Sarcopenia on Thoracic Computed Tomography: Quantitative Assessment of Skeletal Muscle Mass in Patients Undergoing Transcatheter Aortic Valve Replacement.
U. Nemec (2017)
10.1016/j.jtcvs.2016.03.060
Lobectomy versus stereotactic body radiotherapy in healthy patients with stage I lung cancer.
J. Rosen (2016)
10.21037/jtd.2017.12.39
Sarcopenia is a predictor of outcomes after lobectomy.
James Adam Miller (2018)
10.1016/j.athoracsur.2009.06.012
Risk factors for morbidity after lobectomy for lung cancer in elderly patients.
M. Berry (2009)
10.1245/s10434-017-5811-9
Prognostic Significance of Sarcopenia in Patients with Esophagogastric Junction Cancer or Upper Gastric Cancer
Kensuke Kudou (2017)
Physicians and Society of Thoracic Surgeons consensus statement for evaluation and management for high - risk patients with stage I non - small cell lung cancer
JA Howington (2012)
10.1016/j.amjmed.2014.02.007
Muscle mass index as a predictor of longevity in older adults.
P. Srikanthan (2014)
10.1200/JCO.2012.45.2722
Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index.
L. Martin (2013)
10.1016/j.surg.2014.04.027
Sarcopenia is a predictor of outcomes in very elderly patients undergoing emergency surgery.
Yang Du (2014)
10.1378/chest.12-2395
Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
A. Brunelli (2013)
10.3322/canjclin.39.6.399
Cancer statistics
N. Dubrawsky (1989)
10.1093/jjco/hyx009
Sarcopenia is a novel poor prognostic factor in male patients with pathological Stage I non-small cell lung cancer
T. Tsukioka (2017)
10.1016/j.jtcvs.2013.09.065
Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.
N. Altorki (2014)
10.1056/NEJMoa1102873
Reduced lung-cancer mortality with low-dose computed tomographic screening.
D. Aberle (2011)
10.1016/j.lungcan.2016.08.007
Clinical implications of sarcopenia in patients undergoing complete resection for early non-small cell lung cancer.
Y. Suzuki (2016)
10.1007/s00421-011-1952-x
Effects of age and inactivity due to prolonged bed rest on atrophy of trunk muscles
T. Ikezoe (2011)
10.1111/1759-7714.12352
Clinical outcomes of video‐assisted thoracic surgery and stereotactic body radiation therapy for early‐stage non‐small cell lung cancer: A meta‐analysis
Longfei Ma (2016)
10.1378/CHEST.104.1.155
Preoperative prediction of pulmonary complications following thoracic surgery.
R. Dales (1993)
10.1016/j.jamcollsurg.2016.02.020
Analyzing Risk Factors for Morbidity and Mortality after Lung Resection for Lung Cancer Using the NSQIP Database.
R. Jean (2016)
10.1093/OXFORDJOURNALS.AJE.A009520
Epidemiology of sarcopenia among the elderly in New Mexico.
R. Baumgartner (1998)
10.1016/j.athoracsur.2016.06.077
Body Mass Index and Total Psoas Area Affect Outcomes in Patients Undergoing Pneumonectomy for Cancer.
R. Hervochon (2017)
10.1139/H08-075
A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care.
M. Mourtzakis (2008)
10.1016/j.athoracsur.2016.06.032
A Risk Score to Assist Selecting Lobectomy Versus Sublobar Resection for Early Stage Non-Small Cell Lung Cancer.
B. Gulack (2016)
Physicians evidence - based clinical practice guidelines
NK Altorki (2013)
10.1378/chest.12-2359
Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
J. Howington (2013)
10.1016/j.jss.2016.12.014
Sarcopenia: a new predictor of postoperative complications for elderly gastric cancer patients who underwent radical gastrectomy.
Chong-Jun Zhou (2017)
10.1513/AnnalsATS.201307-229OC
Quantitative computed tomography measures of pectoralis muscle area and disease severity in chronic obstructive pulmonary disease. A cross-sectional study.
M. McDonald (2014)
10.3322/caac.21387
Cancer statistics, 2017
R. Siegel (2017)
10.1093/annonc/mdu540
The prevalence and outcomes of frailty in older cancer patients: a systematic review.
C. Handforth (2015)
10.1016/j.athoracsur.2014.07.007
Predictors of mortality after surgical management of lung cancer in the National Cancer Database.
J. Rosen (2014)
10.1513/AnnalsATS.201507-446OC
Quantitative Assessment of Erector Spinae Muscles in Patients with Chronic Obstructive Pulmonary Disease. Novel Chest Computed Tomography-derived Index for Prognosis.
K. Tanimura (2016)
10.1371/journal.pone.0139749
Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index
Younak Choi (2015)
Physicians evidence - based clinical practice guidelines
Y Du (2013)



This paper is referenced by
10.1007/s11748-019-01125-3
Sarcopenia predicts poor postoperative outcome in elderly patients with lung cancer
Y. Kawaguchi (2019)
10.3390/cancers12020266
Pre-Disease and Pre-Surgery BMI, Weight Loss and Sarcopenia Impact Survival of Resected Lung Cancer Independently of Tumor Stage
P. Icard (2020)
10.21037/jtd.2018.08.35
Editorial: refining the estimation of fitness for surgery.
B. Ryan (2018)
10.1007/s12603-018-1147-9
A Cross-Sectional Study of the Association Between Arterial Stiffness and Sarcopenia in Chinese Community-Dwelling Elderly Using the Asian Working Group for Sarcopenia Criteria
L. Zhang (2018)
10.1093/ejcts/ezz304
A risk model to predict 2-year survival after VATS lobectomy for non-small-cell lung cancer.
H. X. Tan (2019)
10.1183/23120541.00205-2019
Quantity and quality of antigravity muscles in patients undergoing living-donor lobar lung transplantation: 1-year longitudinal analysis using chest computed tomography images
Yohei Oshima (2020)
10.21037/jtd.2017.12.39
Sarcopenia is a predictor of outcomes after lobectomy.
J. A. Miller (2018)
10.1007/s00384-018-3128-1
Can sarcopenia be a predictor of prognosis for patients with non-metastatic colorectal cancer? A systematic review and meta-analysis
Guangwei Sun (2018)
10.21037/JTD.2019.08.16
Effect of progressive sarcopenia during postoperative 6 months on long-term prognosis of completely resected lung cancer.
M. Nagata (2019)
10.1186/s12880-019-0316-6
CoreSlicer: a web toolkit for analytic morphomics
L. Mullie (2019)
10.1016/j.pharmthera.2018.12.003
Body composition and sarcopenia: The next‐generation of personalized oncology and pharmacology?
M. Hilmi (2019)
10.1016/j.athoracsur.2019.10.041
Low Thoracic Skeletal Muscle Area Predicts Morbidity after Pneumonectomy for Lung Cancer.
M. Madariaga (2019)
10.1038/s41598-020-59100-5
Early decrease in erector spinae muscle area and future risk of mortality in idiopathic pulmonary fibrosis
A. Nakano (2020)
10.1007/s11748-019-01144-0
It is time to consider incorporating sarcopenia assessment in the surgical management of non-small-cell lung cancer
Han-Yu Deng (2019)
10.1016/j.jjcc.2020.07.010
Sarcopenia as a prognostic factor for outcomes after isolated tricuspid valve surgery.
Jimi Oh (2020)
10.3390/jcm8081257
Low Muscle Mass as a Prognostic Factor for Early Postoperative Outcomes in Pediatric Patients Undergoing the Fontan Operation: A Retrospective Cohort Study
Jimi Oh (2019)
10.1016/j.rmed.2018.10.023
Quantitative assessment of erector spinae muscles in patients with Mycobacterium avium complex lung disease.
Takanori Asakura (2018)
10.1111/1759-7714.13173
Risk factors and cancer recurrence associated with postoperative complications after thoracoscopic lobectomy for clinical stage I non‐small cell lung cancer
Takeo Nakada (2019)
10.1016/j.critrevonc.2019.06.007
Muscle derangement and alteration of the nutritional machinery in NSCLC.
I. Trestini (2019)
10.1016/j.athoracsur.2019.04.090
Computed Tomography-Assessed Skeletal Muscle Mass as a Predictor of Outcomes in Lung Cancer Surgery.
J. Nishimura (2019)
10.1007/978-3-030-47404-1_9
Does Assessment of Frailty and Sarcopenia in Lung Resection Candidates Affect Patient Selection
M. Huisingh-Scheetz (2020)
10.21037/jtd.2018.08.34
Sarcopenia in resected non-small cell lung cancer: let's move to patient-directed strategies.
P. Icard (2018)
10.1097/RTI.0000000000000428
Computed Tomography–based Body Composition Analysis and Its Role in Lung Cancer Care
Amelie S Troschel (2019)
10.1053/j.jvca.2020.11.025
"Fit for Surgery? What's New in Preoperative Assessment of the High-Risk Patient Undergoing Pulmonary Resection".
C. Hanley (2020)
Semantic Scholar Logo Some data provided by SemanticScholar